Skip to main content

A comparison of performance of anti-cyclic citrullinated peptide 2 and citrullinated protein antibodies in the diagnosis of rheumatoid arthritis in Iranian patients

Rheumatology International volume 30, pages 461–466 (2010)Cite this article

Abstract

Antibodies to citrullinated proteins and rheumatoid factor (RF) are widely used in patients with rheumatoid arthritis (RA) and the antibodies to citrullinated proteins appear to be the most specific markers of the disease. The objective was to compare the diagnostic performance of the anti-cyclic citrullinated peptide 2 (anti-CCP2) and citrullinated protein Antibodies (CPA) with RF in the diagnosis of RA. Serum samples of 139 patients with RA and 131 patients with other rheumatic diseases were checked for anti-CCP2, CPA uses citrullinated recombinant rat filaggrin as the antigen assay, and RF. The specificity, sensitivity, and receiver operating characteristic (ROC) of tests were then compared. The sensitivity of anti-CCP2, CPA, and RF were 82.7, 83.5, and 61.5%, respectively. The specificities of the tests were 91.2, 78.6, and 90.5%, respectively. The area under ROC curves for the tests were 0.925, 0.890, and 0.847, respectively. Exclusion of overlaps was associated with improved specificity for CPA but no change in the specificity of RF and anti-CCP. The sensitivity of anti-CCP2, CPA, and RF were 66.7, 77.8, and 51.9% for patients with early RA, respectively. The findings of the present study indicate that anti-CCP2 might be of a better diagnostic value for the diagnosis of RA. They also showed that CPA and in the second place anti-CCP2 were useful in the diagnosis of early RA.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Van Boekel MA, Vossenaar ER, Van den Hoogen FH, Van Venrooij WJ (2002) Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 4:87–93. doi:10.1186/ar395

    Article  PubMed  Google Scholar 

  2. Steiner G, Smolen J (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4(Suppl 2):S1–S5. doi:10.1186/ar551

    Article  PubMed  Google Scholar 

  3. Lee DM, Schur PH (2003) Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 62:870–874. doi:10.1136/ard.62.9.870

    Article  CAS  PubMed  Google Scholar 

  4. Weinblatt ME, Schur PH (1980) Rheumatoid factor detection by nephelometry. Arthritis Rheum 23:777–779. doi:10.1002/art.1780230611

    Article  CAS  PubMed  Google Scholar 

  5. Saraux A, Berthelot JM, Chales G, Le Henaff C, Mary JY, Thorel V et al (2002) Value of laboratory tests in early prediction of rheumatoid arthritis. Arthritis Rheum 47:155–165. doi:10.1002/art.10241

    Article  PubMed  Google Scholar 

  6. Bas S, Perneger TV, Kunzle E, Vischer TL (2002) Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors. Ann Rheum Dis 61:505–510. doi:10.1136/ard.61.6.505

    Article  CAS  PubMed  Google Scholar 

  7. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47:1089–1093

    CAS  PubMed  Google Scholar 

  8. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155–163. doi:10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3

    Article  CAS  PubMed  Google Scholar 

  9. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N (1966) Cryoglobulinemia—a clinical and laboratory study. Am J Med 40:837–856. doi:10.1016/0002-9343(66)90200-2

    Article  CAS  PubMed  Google Scholar 

  10. Mikkelsen WM, Dodge HJ, Duff IF, Kato H (1967) Estimates of the prevalence of rheumatic diseases in the population of Tecumseh, Michigan, 1959–1960. J Chronic Dis 20:351–369. doi:10.1016/0021-9681(67)90009-4

    Article  CAS  PubMed  Google Scholar 

  11. Bartfeld H (1960) Incidence and significance of seropositive tests for rheumatoid factor in non-rheumatoid disease. Ann Intern Med 52:1059–1066

    Google Scholar 

  12. Schellekens GA, De Jong BA, Van Den Hoogen FH, Van De Putte LB, Van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis specific autoantibodies. J Clin Invest 101:273–281. doi:10.1172/JCI1316

    Article  CAS  PubMed  Google Scholar 

  13. Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C et al (1999) The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 162:585–594

    CAS  PubMed  Google Scholar 

  14. Pruijn GJ, M Vossenaarl ER, Drijfhout J, van Venrooij WJ, Zendman AJ (2005) Anti-CCP antibody detection facilitates early diagnosis and prognosis of rheumatoid arthritis. Curr Rheumatol Rep 1:1–7. doi:10.2174/1573397052954208

  15. Emery P (1994) The optimal management of early rheumatoid disease: the diagnostic performances of Anti-CCP and AFA. Br J Rheumatol 33:765–768. doi:10.1093/rheumatology/33.8.765

    Article  CAS  PubMed  Google Scholar 

  16. van Aken J, Lard LR, le Cessie S, Hazes JM, Breedveld FC, Huizinga TWJ (2004) Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 63:274–279. doi:10.1136/ard.2003.010298

    Article  PubMed  Google Scholar 

  17. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS (2004) Benefit of very early referral and very early therapy with disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43:906–914. doi:10.1093/rheumatology/keh199

    Article  CAS  Google Scholar 

  18. van Gaalen FA, Visser H, Huizinga TW (2005) A comparison of the diagnostic accuracy and prognostic value of the first- and second anti-cyclic citrullinated peptides autoantibody (CCP1 and CCP2). Tests Rheumatoid Arthritis Ann Rheum Dis 64(10):1510–1512. doi:10.1136/ard.2004.035089

    Google Scholar 

  19. Dubucquoi S, Solau-Gervais E, Lefranc D, Marguerie L, Sibilia J, Goetz J et al (2004) Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis 63:415–419. doi:10.1136/ard.2003.008623

    Article  CAS  PubMed  Google Scholar 

  20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324. doi:10.1002/art.1780310302

    Article  CAS  PubMed  Google Scholar 

  21. Visser H, Gelinck LB, Kampfraath AH, Breedveld FC, Hazes (1996) Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid J M factor assays in rheumatoid arthritis. Ann Rheum Dis 55(3):157–161. doi:10.1136/ard.55.3.157

    Article  CAS  PubMed  Google Scholar 

  22. Westwood OMR, Nelsonl PN, Hay FC (2006) Review. Rheumatoid factors: what’s new? Rheumatology 45:379–385. doi:10.1093/rheumatology/kei228

    Article  CAS  PubMed  Google Scholar 

  23. Quinn MA, Gough AKS, Green MJ, Devlin J, Hensor EMA, Greensteinet A et al (2006) Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology 45(4):478–480. doi:10.1093/rheumatology/kei203

    Article  CAS  PubMed  Google Scholar 

  24. Fernandez-Suarez A, Reneses S, Wichmann I, Criado R, Nunez A (2005) Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis. Clin Chem Lab Med 43(11):1234–1239. doi:10.1515/CCLM.2005.214

    Article  CAS  PubMed  Google Scholar 

  25. Vossenaar ER, van Venrooij WJ (2004) Anti-CCP antibodies, a specific marker for (early) rheumatoid arthritis. Clin Appl Immunol Rev 4:239–262. doi:10.1016/j.cair.2003.11.001

    Article  CAS  Google Scholar 

  26. Vasiliauskiene L, Wiik A, Hoier-Madsen M (2001) Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis. Ann Rheum Dis 60:459–466. doi:10.1136/ard.60.5.459

    Article  CAS  PubMed  Google Scholar 

  27. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS et al (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2:236–243. doi:10.1186/ar93

    Article  CAS  PubMed  Google Scholar 

  28. Kasapcopur O, Altun S, Aslan M, Karaarslan S, Kamburoglu-Göksel A, Saribas S et al (2004) Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 63:1687–1689. doi:10.1136/ard.2003.019331

    Article  CAS  PubMed  Google Scholar 

  29. Choi SW, Lim MK, Shin DH, Park JJ, Shim SC (2005) Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis. J Korean Med Sci 20:473–478

    Article  CAS  PubMed  Google Scholar 

  30. Gao IK, Haas-Wohrle A, Mueller KG, Lorenz HM, Fiehn C (2005) Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: does it help to predict the diagnosis before referral to a rheumatologist? Ann Rheum Dis 64:1516–1517. doi:10.1136/ard.2005.035444

    Article  CAS  PubMed  Google Scholar 

  31. Kastbom A, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63:1085–1089. doi:10.1136/ard.2003.016808

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank the Office of Vice Chancellor for Research of Shiraz University of Medical Sciences for financial support and Dr. Nekooiyan, the Center for Development of Clinical Research of Nemazi Hospital for editorial assistance.

Author information

Affiliations

  1. Division of Rheumatology, Department of Internal Medicine, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran

    Elham Aflaky & Saeedeh Shenavandeh

  2. Department of Pathology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran

    Mohammad Javad Ashraf

Authors
  1. Elham Aflaky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saeedeh Shenavandeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Javad Ashraf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Saeedeh Shenavandeh.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Aflaky, E., Shenavandeh, S. & Ashraf, M.J. A comparison of performance of anti-cyclic citrullinated peptide 2 and citrullinated protein antibodies in the diagnosis of rheumatoid arthritis in Iranian patients. Rheumatol Int 30, 461–466 (2010). https://doi.org/10.1007/s00296-009-0980-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-0980-x

Keywords

  • Arthritis
  • Rheumatoid
  • Rheumatoid factor
  • Anti-cyclic citrullinated peptide 2
  • Citrullinated protein antibody